Vital Signs - The Next Major Medical Device Blockbuster: Transcatheter Valves


USD 1,500.00

* Required Fields

USD 1,500.00


Be the first to review this product

This issue of Vital Signs, released on October 5, 2009, provides a strategic overview of the opportunity of transcatheter valves in the medical devices space. Additionally, a company spotlight is provided for Cardiac Dimensions, Inc., an emerging company focused on offering new avenues of treatment for underserved CHF patients. Reimbursement and regulatory news from the FDA is also provided for the week of September 21, 2009.

Table of Contents

Vital Signs - The Next Major Medical Device Blockbuster: Transcatheter ValvesVital Signs: 5 October 2009This week's issue:

Related Research

Release Date : 21-Nov-18

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.